Chorionic Gonadotropin (Human)
- Generic Name
- Chorionic Gonadotropin (Human)
- Brand Names
- Novarel, Pregnyl
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 9002-61-3
- Unique Ingredient Identifier
- 20ED16GHEB
- Background
Human chorionic gonadotropin (HCG), a polypeptide hormone produced by the human placenta. Endogenously produced HCG interacts with the LHCG receptor of the ovary and promotes the maintenance of the corpus luteum during the beginning of pregnancy. This allows the corpus luteum to continuously secrete the hormone progesterone during the first trimester, which ...
- Indication
For the treatment of prepubertal cryptorchidism (not due to anatomical obstruction), for the treatment of selected cases of hypogonadotropic hypogonadism (hypogonadism secondary to a pituitary deficiency) in males and for the induction of ovulation and pregnancy in the anovulatory, infertile woman in whom the cause of anovulation is secondary and not due to ...
- Associated Conditions
- Idiopathic Hypogonadotropic Hypogonadism, Undescended Testis, Secondary Hypogonadotrophic hypogonadism
- Associated Therapies
- Ovulation induction therapy, Stimulation of spermatogenesis therapy
Oxytocin Versus Human Chorionic Gonadotropin as Trigger in Ovulation Induction
- Conditions
- Interventions
- First Posted Date
- 2024-12-09
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- Shakeela Ishrat
- Target Recruit Count
- 60
- Registration Number
- NCT06725004
- Locations
- 🇧🇩
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Effects of Intrauterine Flushing With Human Chorionic Gonadotropin on ICSI Outcome
- First Posted Date
- 2024-11-12
- Last Posted Date
- 2024-11-12
- Lead Sponsor
- Omayma Ismail Khalaf
- Target Recruit Count
- 90
- Registration Number
- NCT06684951
- Locations
- 🇮🇶
High Institute for Infertility Diagnosis and Assisted Reproductive Technology, Baghdad, Iraq
To Investigate Efficacy and Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant FSH as Reference
- First Posted Date
- 2023-10-19
- Last Posted Date
- 2024-12-03
- Lead Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Target Recruit Count
- 176
- Registration Number
- NCT06091436
- Locations
- 🇨🇳
The Sixth Affiliated Hospital, Sun Yat-sen University Guangdong Gastrointestinal Hospital, Guangzhou, Guangdong, China
Two Different Types of Luteal Phase Support in Natural Cycle Frozen Embryo Transfer and Its Effect on Pregnancy Rates
- Conditions
- Interventions
- First Posted Date
- 2023-05-01
- Last Posted Date
- 2023-05-01
- Lead Sponsor
- Shaare Zedek Medical Center
- Target Recruit Count
- 144
- Registration Number
- NCT05838105
- Locations
- 🇮🇱
Shaare Zedek medical center, Jerusalem, Israel
Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter Syndrome
- Conditions
- Interventions
- First Posted Date
- 2022-10-19
- Last Posted Date
- 2024-01-05
- Lead Sponsor
- Georgios Papadakis
- Target Recruit Count
- 150
- Registration Number
- NCT05586802
- Locations
- 🇨🇭
Service of Endocrinology, Diabetes & Metabolism, Lausanne, Switzerland
Clinical Research Study to Learn About the Effect and Safety of Different Doses of FE 999302 When Given as a Single Dose for Final Development of the Eggs After Ovarian Stimulation
- First Posted Date
- 2022-10-07
- Last Posted Date
- 2023-01-09
- Lead Sponsor
- Ferring Pharmaceuticals
- Registration Number
- NCT05571111
- Locations
- 🇪🇸
Ferring Investigational Site, Valencia, Spain
Relationship Between Some Vitamins and Antioxidants With in Vitro Fertilization Outcomes
- First Posted Date
- 2022-05-26
- Last Posted Date
- 2022-05-26
- Lead Sponsor
- Damascus University
- Target Recruit Count
- 60
- Registration Number
- NCT05393011
- Locations
- 🇸🇾
Damascus University, Damascus, Syrian Arab Republic
🇸🇾Orient Hospital, Damascus, Syrian Arab Republic
HOPE Trial hCG or Progesterone Effect on Recurrent Pregnancy Loss
- Conditions
- Interventions
- First Posted Date
- 2022-05-09
- Last Posted Date
- 2022-05-09
- Lead Sponsor
- Wake Forest University Health Sciences
- Registration Number
- NCT05365464
Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids
- Conditions
- Interventions
- First Posted Date
- 2021-11-17
- Last Posted Date
- 2024-10-21
- Lead Sponsor
- Masonic Cancer Center, University of Minnesota
- Target Recruit Count
- 55
- Registration Number
- NCT05123040
- Locations
- 🇺🇸
Masonic Cancer Center at University of Minnesota, Minneapolis, Minnesota, United States
Progestin-primed Ovarian Stimulation Protocol Versus GnRH Antagonist Protocol in Polycystic Ovary Syndrome Patients Undergoing IVF/ICSI Cycles
- Conditions
- Interventions
- First Posted Date
- 2021-11-09
- Last Posted Date
- 2021-11-09
- Lead Sponsor
- Mansoura University
- Target Recruit Count
- 200
- Registration Number
- NCT05112692
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.